Ivar Hompland - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ivar Hompland

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 3, 2018

Ivar Hompland, Toto Hølmebakk, Kjetil Boye, et al.

Cancer Immunology, Immunotherapy : CII|February 13, 2021

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trialKjetil Boye, Alessandra Longhi, Tormod Guren, et al.

European Journal of Cancer (Oxford, England : 1990)|May 14, 2021

Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma StudyIvar Hompland, Stefano Ferrari, Stefan Bielack, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 3, 2018

Ivar Hompland, Toto Hølmebakk, Kjetil Boye, et al.

Cancer Immunology, Immunotherapy : CII|February 13, 2021

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trialKjetil Boye, Alessandra Longhi, Tormod Guren, et al.

European Journal of Cancer (Oxford, England : 1990)|May 14, 2021

Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma StudyIvar Hompland, Stefano Ferrari, Stefan Bielack, et al.

Pageof 3